Diabetes, Vol 46, Issue 7 1120-1123, Copyright © 1997 by American Diabetes Association

ARTICLES

Improved human islet isolation using a new enzyme blend, liberase

E Linetsky, R Bottino, R Lehmann, R Alejandro, L Inverardi and C Ricordi
Diabetes Research Institute, University of Miami School of Medicine, and the Miami Veterans Administration Medical Center, Florida 33136, USA.

Enzymatic digestion of donor pancreases is a vital step in human and large mammalian islet isolation. The variable enzymatic activities of different batches of commercially available collagenase is a major obstacle in achieving reproducibility in islet isolation procedures. In the present work, the effectiveness of Liberase, a standardized mixture of highly purified enzymes recently developed for the separation of human islets, was compared with that of a traditional collagenase preparation (type P). The results of 50 islet isolations using Liberase enzyme were compared with those of 36 isolations with collagenase, type P. No significant differences in donor age, cold ischemia time, digestion time, or weight of the pancreases were observed between the two groups. Islet yield was significantly higher in the group where the Liberase enzyme was used. All parameters examined (islet number, islet number per gram of tissue, islet equivalent number, and islet equivalent number per gram of tissue) were significantly improved when Liberase enzyme was used. Different lots of Liberase enzyme were tested, and no difference was observed. Islets isolated with Liberase enzyme were also of larger size and were much less fragmented, suggesting a gentler enzymatic action and better preservation of anatomical integrity. Islets isolated with Liberase enzyme, assessed both in vitro and in vivo, revealed a functional profile similar to that of islets separated with collagenase. Liberase enzyme appears, therefore, to represent a new powerful tool for improving the quality of human islet isolation.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. C. Lawrence, K. McGlynn, B. Naziruddin, M. F. Levy, and M. H. Cobb Inaugural Article: Differential regulation of CHOP-10/GADD153 gene expression by MAPK signaling in pancreatic beta-cells PNAS, July 10, 2007; 104(28): 11518 - 11525. [Abstract] [Full Text] [PDF]

				Q. Huang, S. Bu, Y. Yu, Z. Guo, G. Ghatnekar, M. Bu, L. Yang, B. Lu, Z. Feng, S. Liu, et al. Diazoxide Prevents Diabetes through Inhibiting Pancreatic {beta}-Cells from Apoptosis via Bcl-2/Bax Rate and p38-{beta} Mitogen-Activated Protein Kinase Endocrinology, January 1, 2007; 148(1): 81 - 91. [Abstract] [Full Text] [PDF]

				A. S. Narang and R. I. Mahato Biological and biomaterial approaches for improved islet transplantation. Pharmacol. Rev., June 1, 2006; 58(2): 194 - 243. [Abstract] [Full Text] [PDF]

				M.-M. Dolmans, N. Michaux, A. Camboni, B. Martinez-Madrid, A. Van Langendonckt, S. Annarita Nottola, and J. Donnez Evaluation of Liberase, a purified enzyme blend, for the isolation of human primordial and primary ovarian follicles Hum. Reprod., February 1, 2006; 21(2): 413 - 420. [Abstract] [Full Text] [PDF]

				S. Park, X. Dong, T. L. Fisher, S. Dunn, A. K. Omer, G. Weir, and M. F. White Exendin-4 Uses Irs2 Signaling to Mediate Pancreatic beta Cell Growth and Function J. Biol. Chem., January 13, 2006; 281(2): 1159 - 1168. [Abstract] [Full Text] [PDF]

				E. A. Ryan, B. W. Paty, P. A. Senior, D. Bigam, E. Alfadhli, N. M. Kneteman, J. R.T. Lakey, and A.M. J. Shapiro Five-Year Follow-Up After Clinical Islet Transplantation Diabetes, July 1, 2005; 54(7): 2060 - 2069. [Abstract] [Full Text] [PDF]

				K. Maedler, R. D. Carr, D. Bosco, R. A. Zuellig, T. Berney, and M. Y. Donath Sulfonylurea Induced {beta}-Cell Apoptosis in Cultured Human Islets J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 501 - 506. [Abstract] [Full Text] [PDF]

				E. Zeender, K. Maedler, D. Bosco, T. Berney, M. Y. Donath, and P. A. Halban Pioglitazone and Sodium Salicylate Protect Human {beta}-Cells against Apoptosis and Impaired Function Induced by Glucose and Interleukin-1{beta} J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5059 - 5066. [Abstract] [Full Text] [PDF]

				K. Maedler, J. Storling, J. Sturis, R. A. Zuellig, G. A. Spinas, P. O.G. Arkhammar, T. Mandrup-Poulsen, and M. Y. Donath Glucose- and Interleukin-1{beta}-Induced {beta}-Cell Apoptosis Requires Ca2+ Influx and Extracellular Signal-Regulated Kinase (ERK) 1/2 Activation and Is Prevented by a Sulfonylurea Receptor 1/Inwardly Rectifying K+ Channel 6.2 (SUR/Kir6.2) Selective Potassium Channel Opener in Human Islets Diabetes, July 1, 2004; 53(7): 1706 - 1713. [Abstract] [Full Text] [PDF]

				L. Farilla, A. Bulotta, B. Hirshberg, S. Li Calzi, N. Khoury, H. Noushmehr, C. Bertolotto, U. Di Mario, D. M. Harlan, and R. Perfetti Glucagon-Like Peptide 1 Inhibits Cell Apoptosis and Improves Glucose Responsiveness of Freshly Isolated Human Islets Endocrinology, December 1, 2003; 144(12): 5149 - 5158. [Abstract] [Full Text] [PDF]

				R. J. T. Owen, E. A. Ryan, K. O'Kelly, J. R. T. Lakey, M. C. McCarthy, B. W. Paty, D. L. Bigam, N. M. Kneteman, G. S. Korbutt, R. V. Rajotte, et al. Percutaneous Transhepatic Pancreatic Islet Cell Transplantation in Type 1 Diabetes Mellitus: Radiologic Aspects Radiology, October 1, 2003; 229(1): 165 - 170. [Abstract] [Full Text] [PDF]

				A. M. J. Shapiro Islet Transplants and Impact on Secondary Diabetic Complications: Does C-Peptide Protect the Kidney? J. Am. Soc. Nephrol., August 1, 2003; 14(8): 2214 - 2216. [Full Text] [PDF]

				C. Ricordi Lilly Lecture 2002: Islet Transplantation: A Brave New World Diabetes, July 1, 2003; 52(7): 1595 - 1603. [Full Text] [PDF]

				J. Eeckhoute, E. Moerman, T. Bouckenooghe, B. Lukoviak, F. Pattou, P. Formstecher, J. Kerr-Conte, B. Vandewalle, and B. Laine Hepatocyte Nuclear Factor 4{alpha} Isoforms Originated from the P1 Promoter Are Expressed in Human Pancreatic {beta}-Cells and Exhibit Stronger Transcriptional Potentials than P2 Promoter-Driven Isoforms Endocrinology, May 1, 2003; 144(5): 1686 - 1694. [Abstract] [Full Text] [PDF]

				H. Brandhorst, D. Brandhorst, F. Hesse, D. Ambrosius, M. Brendel, Y. Kawakami, and R. G. Bretzel Successful Human Islet Isolation Utilizing Recombinant Collagenase Diabetes, May 1, 2003; 52(5): 1143 - 1146. [Abstract] [Full Text] [PDF]

				E. A. Ryan, J. R.T. Lakey, B. W. Paty, S. Imes, G. S. Korbutt, N. M. Kneteman, D. Bigam, R. V. Rajotte, and A.M. J. Shapiro Successful Islet Transplantation: Continued Insulin Reserve Provides Long-Term Glycemic Control Diabetes, July 1, 2002; 51(7): 2148 - 2157. [Abstract] [Full Text] [PDF]

				A. Shiroi, M. Yoshikawa, H. Yokota, H. Fukui, S. Ishizaka, K. Tatsumi, and Y. Takahashi Identification of Insulin-Producing Cells Derived from Embryonic Stem Cells by Zinc-Chelating Dithizone Stem Cells, July 1, 2002; 20(4): 284 - 292. [Abstract] [Full Text] [PDF]

				K. Maedler, A. Fontana, F. Ris, P. Sergeev, C. Toso, J. Oberholzer, R. Lehmann, F. Bachmann, A. Tasinato, G. A. Spinas, et al. FLIP switches Fas-mediated glucose signaling in human pancreatic beta cells from apoptosis to cell replication PNAS, June 11, 2002; 99(12): 8236 - 8241. [Abstract] [Full Text] [PDF]

				K. Maedler, G. A. Spinas, R. Lehmann, P. Sergeev, M. Weber, A. Fontana, N. Kaiser, and M. Y. Donath Glucose Induces {beta}-Cell Apoptosis Via Upregulation of the Fas Receptor in Human Islets Diabetes, August 1, 2001; 50(8): 1683 - 1690. [Abstract] [Full Text] [PDF]

				E. A. Ryan, J. R.T. Lakey, R. V. Rajotte, G. S. Korbutt, T. Kin, S. Imes, A. Rabinovitch, J. F. Elliott, D. Bigam, N. M. Kneteman, et al. Clinical Outcomes and Insulin Secretion After Islet Transplantation With the Edmonton Protocol Diabetes, April 1, 2001; 50(4): 710 - 719. [Abstract] [Full Text]

				A.M. J. Shapiro, J. R.T. Lakey, E. A. Ryan, G. S. Korbutt, E. Toth, G. L. Warnock, N. M. Kneteman, and R. V. Rajotte Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen N. Engl. J. Med., July 27, 2000; 343(4): 230 - 238. [Abstract] [Full Text] [PDF]

				S. Bonner-Weir, M. Taneja, G. C. Weir, K. Tatarkiewicz, K.-H. Song, A. Sharma, and J. J. O'Neil In vitro cultivation of human islets from expanded ductal tissue PNAS, July 5, 2000; 97(14): 7999 - 8004. [Abstract] [Full Text] [PDF]

				J. Seufert, T. J. Kieffer, C. A. Leech, G. G. Holz, W. Moritz, C. Ricordi, and J. F. Habener Leptin Suppression of Insulin Secretion and Gene Expression in Human Pancreatic Islets: Implications for the Development of Adipogenic Diabetes Mellitus J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 670 - 676. [Abstract] [Full Text]

				N. Giannoukakis, W. A. Rudert, M. Trucco, and P. D. Robbins Protection of Human Islets from the Effects of Interleukin-1beta by Adenoviral Gene Transfer of an Ikappa B Repressor J. Biol. Chem., November 17, 2000; 275(47): 36509 - 36513. [Abstract] [Full Text] [PDF]